Skip to main contentLast updated: 17-Nov-2026
Tapping Book on WhatsApp will likely open the WhatsApp app on your phone.

Dr Harsh Shah
MS, MCh (Surgical Gastroenterology), DrNB (Surgical Gastroenterology)
Registered with Gujarat Medical Council, Reg. No. G-38738
Stomach Cancer Surgeon
Dr. Jivraj Mehta Hospital, Vasna, Ahmedabad · 18 years of experience
In short
GIST is a rare cancer. Only a few people in every million are told they have one each year, and most are past the age of 50.
About six in every ten start in the stomach. The rest start in the small bowel, the rectum and, rarely, the food pipe.
Doctors sort a GIST in three ways: how the cells look, which gene change drives them, and how likely the tumour is to return. The gene change decides the medicine.
For the whole story of GIST, from the first test to imatinib and surgery, read our GIST treatment in Ahmedabad page. This post explains only how common GIST is and how it is classified.
A GIST is rare. Across the world, a few people in every million are diagnosed each year, which makes it far less common than stomach cancer of the usual kind.
Rare does not mean unimportant. Because the disease is uncommon, many general hospitals see only a few patients in a year. The way a GIST is handled in the first operation can change what comes after.
Most patients are between 55 and 70 years old. Men and women are affected about equally, with a very slight lead among men.
| Question | What is known |
|---|---|
| Usual age | The sixth and seventh decade of life; Indian hospital series report a slightly younger average |
| Men or women | Nearly equal; one rare type, linked to a gene change in the SDH family, is seen more often in young women |
| Children and young adults | Rare; when it happens it usually has a different gene change, and it needs a specialist team |
| Family history | Most GISTs happen by chance; a few run in families through a changed gene |
| Ethnic or regional differences | No clear difference in how often it occurs |
A person with the inherited condition called neurofibromatosis type 1 has a higher chance of GIST, often in the small bowel and in more than one place. Such patients need a different plan from the usual one.
The stomach is the commonest site, followed by the small bowel. A GIST can start anywhere along the food canal, and rarely outside it.
| Site | How often | Why it matters |
|---|---|---|
| Stomach | About six in ten | Often removable with a small wedge of the stomach wall, by keyhole in suitable lumps |
| Small bowel | About a quarter | Often found late, after bleeding or a blockage |
| Rectum and colon | A small share | A low rectal lump may need a larger operation, so medicine before surgery is often used |
| Food pipe | Rare | Usually the lower part; may be shelled out from the wall |
| Outside the gut | Rare | Grows in the fat sheet or the back of the belly; the gene change often differs |
The site also gives a clue to the gene change. A stomach GIST can belong to any of the main types. A GIST with an SDH change is almost always in the stomach, while one linked to neurofibromatosis is mostly in the small bowel.
A GIST grows from the pacemaker cells of the gut, called the interstitial cells of Cajal. These cells set the rhythm of the squeeze that moves food along.
This history matters today. If an old report says “smooth muscle tumour” of the stomach, it is worth asking a pathologist to re-test the slides with modern stains.
A GIST is classified on three separate axes: how the cells look, which gene change drives them, and how likely the tumour is to return after surgery.
| Axis | Groups | What it decides |
|---|---|---|
| Look under the microscope | Spindle cells (most), round or epithelioid cells, mixed | Describes the tumour; a weak guide to behaviour on its own |
| Gene change | KIT (the large majority), PDGFRA, SDH-deficient, and a few rarer types | Which medicine will work, and at what dose |
| Risk of return | Very low, low, intermediate, high | Whether tablets are advised after surgery, and for how long |
Risk is worked out from the size of the tumour, how fast its cells are dividing, where it started, and whether it burst before or during surgery. A tumour in the stomach carries a lower risk than a tumour of the same size in the small bowel.
Each gene type responds differently. Most KIT types respond well to imatinib, a few PDGFRA types do not respond at all, and SDH-deficient tumours respond poorly.
This is why a gene test is worth doing before any tablet is started. Our post on how a GIST is confirmed with CT, scope and biopsy explains when it is sent.
Not always. Tiny GIST-like growths are found in the stomach of many older adults on autopsy, and most of them never grow into a problem.
The post on the ultrasound scope explains how a small lump is judged. If you are worried about symptoms, read the symptoms that can point to a GIST.
No. Usual stomach cancer starts in the lining. A GIST starts in the muscle layer of the wall, from the pacemaker cells of the gut, and it is treated with different medicines.
A GIST is treated as a cancer because it can grow and spread. The risk varies a lot: some are very low risk, some are high risk. The risk group is worked out from size, cell division and site.
Most happen by chance. A few run in families through a changed gene, and some are linked to conditions such as neurofibromatosis. If more than one family member has one, ask for genetic counselling.
The gene change inside the tumour decides which medicine will work and at what dose. A report that names only a GIST, without the gene type, is incomplete when medicine is planned.
Many tiny ones never cause trouble. A lump of about a centimetre or less, with a calm look on an ultrasound scope, is often watched. A larger or growing lump needs tissue and a plan.
No, though old reports used that name for what we now call a GIST. Special stains and gene tests separate them today, and the treatment is different.
It tells how likely the tumour is to come back after surgery. It depends on size, how fast the cells divide, the site, and whether the tumour burst. It guides whether tablets are advised after the operation.
For the full picture of GIST and its treatment, start at the GIST treatment in Ahmedabad page. For questions before you travel, call +91-63555-64601.
Dr Harsh Shah — Dr. Jivraj Mehta Hospital, Vasna, Ahmedabad
Dr. Jivraj Mehta Hospital, Dr Jivraj Mehta Marg, Vasna, Ahmedabad 380007.
Consultations, review of reports and scans, operations and follow-up. OPD Monday to Saturday, 9 am to 5 pm.
Appointments: +91-63555-64601 · +91-63590-11009 · Hospital 079-2663 6363
Directions to the hospital · WhatsApp +91-63555-64601
Told you have a GIST, or a scan shows a lump in the stomach wall, and you want to know what kind it is? The type decides the medicine and the plan. Dr Harsh Shah, a stomach cancer surgeon in Ahmedabad, goes through your reports with you and explains what they mean. Bring every scan, scope report and biopsy report you have. You can call us or book by message. Call For Appointment Book on WhatsApp Tapping Book on WhatsApp will likely open the WhatsApp app on your phone.
Tapping Book on WhatsApp will likely open the WhatsApp app on your phone.
Swasth Parivar: every week, practical advice on recovery, diet and warning signs. No advertising. Stop any time.
Your number is used for these updates and for the clinic to reach you. It is never sold or passed on. To stop, reply STOP on WhatsApp.